Deva Holding A.S. (IST:DEVA)
Turkey · Delayed Price · Currency is TRY 92.45
+1.90 (2.10%)
Sep 4, 2026, 6:09 PM GMT+3
Deva Holding A.S. Financials Overview
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 20,173 | 19,246 | 20,234 | 16,359 | 8,713 | 2,330 |
Revenue Growth | -7.87% | -4.88% | 23.69% | 87.76% | 273.88% | 25.06% |
Gross Profit Gross Profit Growth | 7,775 | 6,305 | 8,080 | 6,841 | 2,884 | 1,359 |
Operating Income Operating Income Growth | 1,215 | -12.45 | 2,153 | 1,589 | 110.28 | 841.11 |
Net Income Net Income Growth | -975.75 | -806.99 | 90.86 | 4,888 | 851.06 | 1,170 |
Earnings Per Share EPS Growth | -4.88 | -4.03 | 0.45 | 24.44 | 4.25 | 5.85 |
EPS Growth | - | - | -98.14% | 474.32% | -27.27% | 79.61% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Human Pharma Human Pharma Growth | 19,144 | 18,190 | 19,260 | 15,658 | 8,204 | 2,139 |
Other Other Growth | 89.25 | 118.38 | 105.27 | 79.42 | 68.68 | 30.55 |
Veterinary Products Veterinary Products Growth | 939.92 | 937.63 | 868.37 | 621.04 | 439.63 | 161.18 |
Total Total Growth | 20,173 | 19,246 | 20,234 | 16,359 | 8,713 | 2,330 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3,570 | 3,593 | 2,840 | 5,140 | 2,201 | 1,311 |
Total Debt Total Debt Growth | 6,270 | 5,983 | 8,071 | 7,918 | 5,600 | 1,734 |
Net Cash (Debt) Net Cash Growth | -2,700 | -2,390 | -5,230 | -2,778 | -3,399 | -423.21 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -13.50 | -11.95 | -26.15 | -13.89 | -16.99 | -2.12 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 513.07 | 5,285 | 9,852 | 7,157 | 2,262 | 1,248 |
Capital Expenditures CapEx Growth | -531.97 | -505.51 | -1,579 | -764.24 | -1,147 | -337.04 |
Free Cash Flow Free Cash Flow Growth | -18.9 | 4,779 | 8,273 | 6,393 | 1,115 | 910.73 |
Free Cash Flow Growth | - | -42.23% | 29.41% | 473.47% | 22.41% | 140.88% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 38.54% | 32.76% | 39.93% | 41.82% | 33.10% | 58.32% |
Operating Margin | 6.02% | -0.07% | 10.64% | 9.71% | 1.27% | 36.09% |
Pretax Margin | 2.71% | -0.48% | 2.39% | 17.44% | 13.98% | 49.71% |
Profit Margin | -4.84% | -4.19% | 0.45% | 29.88% | 9.77% | 50.21% |
FCF Margin | -0.09% | 24.83% | 40.89% | 39.08% | 12.80% | 39.08% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.250 | - | - | 0.250 | 0.150 | 0.150 |
Dividend Per Share Growth | - | - | - | 66.67% | 0% | 50.00% |
Dividend Yield | 0.26% | - | - | 0.33% | 0.22% | 0.53% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 172.58 | 3.09 | 16.26 | 4.91 |
P/FCF Ratio | - | 2.62 | 1.90 | 2.36 | 12.42 | 6.31 |
PS Ratio | 0.92 | 0.65 | 0.78 | 0.92 | 1.59 | 2.47 |